Trial intelligence / Profile preview

Collaborative Services for Addicted Offenders

NCT01843751Phase 3Completed

Sponsor
University of Wisconsin–Madison
Start
Mar 2013
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Suboxone in opioid use disorder (OUD), sponsored by University of Wisconsin–Madison. Started Mar 2013; status: completed.

02

Drugs

Suboxone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT01843751.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01843751.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call